A study for a 51 year old man who takes Carbidopa - from FDA reports


20 males aged 51 (±5) who take the same drug are studied. This is a personalized study for a 51 year old male patient who has Parkinson's Disease. The study is created by eHealthMe based on reports from FDA.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

What are the drugs?

What are the conditions?

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.

On Mar, 14, 2019

20 males aged 51 (±5) who take Carbidopa are studied.

Number of reports submitted per year:

Carbidopa for a 51-year old man.

Information of the patient in this study:

  • Age: 51
  • Gender: male
  • Conditions: Parkinson's Disease
  • Drugs taken:
    • Carbidopa (carbidopa)

eHealthMe real world results:

Most common side effects over time

< 1 month:
1 - 6 months:
6 - 12 months:
1 - 2 years:
2 - 5 years:
5 - 10 years:
10+ years:
not specified:
  1. Death
  2. Tremor (trembling or shaking movements in one or more parts of your body)
  3. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  4. Weakness
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Fainting (loss of consciousness and postural tone)
  7. Crying
  8. Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
  9. Dizziness
  10. Hepatomegaly (abnormal enlargement of the liver)

Top conditions involved for these people *:

  1. Bipolar Disorder (mood disorder): 2 people, 10.00%
  2. Depression : 2 people, 10.00%
  3. Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 10.00%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%
  5. High Blood Cholesterol : 2 people, 10.00%
  6. High Blood Pressure : 2 people, 10.00%
  7. Insomnia (sleeplessness): 1 person, 5.00%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.00%
  9. Indigestion : 1 person, 5.00%
  10. Weight Decreased : 1 person, 5.00%

Top co-used drugs for these people *:

  1. Azilect (5 people, 25.00%)
  2. Zantac (3 people, 15.00%)
  3. Requip (2 people, 10.00%)
  4. Miralax (2 people, 10.00%)
  5. Galantamine Hydrobromide (2 people, 10.00%)
  6. Fish Oil (2 people, 10.00%)
  7. Namenda (2 people, 10.00%)
  8. Niacin (2 people, 10.00%)
  9. Coq10 (2 people, 10.00%)
  10. Carvedilol (2 people, 10.00%)

* Some reports may have incomplete information.

What is next?

You are not alone:

Related publications that referenced our studies

Related studies:

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.